Registry for patients treated with Inari Medical devices for pulmonary embolism

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects data on patients who have received treatment for pulmonary embolism using Inari Medical devices. It is a global, prospective, non-randomized, multicenter observational study aimed at gathering post-market data on the effectiveness and safety of these devices. Patients who consent and meet eligibility criteria will be monitored for outcomes related to their treatment. The registry aims to enhance understanding of the devices' performance in real-world settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Willing and able to provide informed consent per institution and geographical requirements
2. Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure.
3. Currently within enrollment window relative to their procedure
4. Age ≥ 18 years

Exclusion Criteria:

1. Is or will be inaccessible for registry follow-up
2. Meets exclusion criteria required by local requirements
3. Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry
4. Is pregnant or breastfeeding at the time of enrollment

Where it's running

• La Pitié Salpétrière Hospital
  Paris, France Recruiting
• Vivantes Klinikum im Friedrichshain
  Berlin, Germany Recruiting
• Azienda Ospedaliero Universitaria delle Marche
  Ancona, Italy Recruiting
• Santa Marta Hospital
  Lisbon, Portugal Recruiting
• Southmead Hospital Bristol
  Bristol, United Kingdom Recruiting
• Queen Elizabeth University Hospital
  Glasgow, United Kingdom Recruiting

Study contacts

• Study coordinator: Ida Nelson
• Email: ida.nelson@stryker.com
• Phone: 46 707 723010

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization

  This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.

  Recruiting University of Monastir · Monastir · NCT07863115

• Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE

  This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.

  Recruiting Marmara University Pendik Training and Research Hospital · Istanbul · NCT07805616

• Right heart dysfunction in acute pulmonary embolism: can echocardiography help predict risk

  This study tests whether transthoracic echocardiography can identify right ventricular dysfunction in adults with acute pulmonary embolism to help gauge risk.

  Recruiting Sohag University · Sohag and 1 other locations · NCT07647497

• Aspiration thrombectomy with the Symphony or Prodigy devices

  This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.

  Recruiting at 13 sites Imperative Care, Inc. · Huntsville, Alabama and 12 other locations · NCT07350499

• PERC and YEARS approaches for diagnosing pulmonary embolism in the emergency department.

  This project will test whether using the PERC score and the YEARS algorithm helps emergency doctors decide which adults need D-dimer blood tests or chest CT scans to diagnose pulmonary embolism.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07313501

• Reperfusion options for acute pulmonary embolism

  This project will try catheter-directed interventions or systemic thrombolysis in adults with acute pulmonary embolism to see which approach leads to better outcomes.

  Recruiting at 12 sites Sahlgrenska University Hospital · Aarhus and 12 other locations · NCT07003646

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.